Details
Epigenetic studies are leading to new insights into pathophysiology of disease and opening novel avenues for disease diagnosis and therapies.
Learn more from our featured speakers on how epigenetics can impact both cancer and diabetes.
- Prof. Martin Widschwendter, University of Innsbruck & UCL, presents his work on the potential of characterizing the DNA methylome of cervical cells for risk prediction and early detection of ovarian cancer.
- Dr. Sonia Garcia-Calzon, Lund University, presents on methylation risk scores and sub-grouping of type 2 diabetes (T2D).
Complete the form to access On Demand webinars
Your email address is never shared with third parties.
- Date & Time
- 8 Nov 2023
- Location
- Europe
- Presenter
- Prof. Martin Widschwendter, Dr. Sonia Garcia-Calzon
- Topic
- Complex disease genomics, Genetic & rare diseases